Join IVAC at the 11th biannual International Symposium on Pneumocococci & Pneumococcal Diseases (ISPPD) in Melbourne, Australia, from April 15-19!

We look forward to seeing you in Melbourne to explore the latest research and policy developments related to the diagnosis, prevention, and treatment of pneumococci and pneumococcal diseases. See below for details on where our people will be presenting and leading sessions, and what to find at our ISPPD exhibition booth.

Pre-Symposium Workshops

Getting to the Bottom of Herd Immunity – Featuring Kate O’Brien, MD, MPH, Executive Director, International Vaccine Access Center (IVAC)

Pre-Symposium WS3 | Room 212 | Sunday, April 15 | 14:00-17:00

Adult Pneumococcal Vaccines – Strategies, Opportunities & Challenges for Access and Uptake – Featuring Lois Privor-Dumm, IMBA, Director, Policy, Advocacy and Communications, IVAC

Pre-Symposium WS4 | Room 213 | Sunday, April 15 | 14:00-17:00

Plenary Talks

Indigenous Populations World-Wide – Requirements to Make the Switch for Alternative Dose Vaccine Schedules Among Indigenous Peoples – Laura Hammitt, MD, Associate Professor, Johns Hopkins Bloomberg School of Public Health

Main Hall | Tuesday, April 17 | 11:00-12:30

Lessons from PERCH On Pathogen-Specific Causes Of Pneumonia – Kate O’Brien, MD, MPH

Main Hall | Wednesday, April 18 | 9:00-10:00

Parallel Session

Direct and Indirect Impact of 13v-Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Blantyre, Malawi – Naor Bar-Zeev, PhD, Associate Professor, Johns Hopkins Bloomberg School of Public Health

Room 213 | Tuesday, April 17 | 14:00-15:30

Poster Sessions

Poster Talk

Pneumococcal Conjugate Vaccine Introduction and Uptake Timelines for Gavi-Supported Countries – Lois Privor-Dumm

Tuesday, April 17 | 16:30-17:30 (Location TBD)

Plus, >10 Poster Exhibitions on topics including:

  • Economic consequences of pneumonia in Bangladesh and Uganda
  • Long-term benefits of pneumococcal conjugate vaccine (PCV) introduction in Nepal
  • Household economic impact of hospitalized pneumonia, meningitis, and sepsis in Nepal
  • How PCV can reduce catastrophic health spending in Nepal
  • Systematic review of PCV immunogenicity
  • PCV’s impact on carriage and disease
  • Adult immunization policy landscape 
  • Pneumococcal serotype surveillance in India
  • Vaccine-induced changed in lineages genotypes and strain diversity pneumococcus in Malawi
Exhibition Booth

Browse recent publications and explore two of IVAC’s recently expanded digital tools at our exhibition booth:

  • VIEW-hub is a one-stop shop for presentation-ready visuals on vaccine use, product type, coverage levels, impact assessments, and disease burden. VIEW-hub now has new impact study details, country profiles, and subnational data, plus a mobile application. Explore at VIEW-hub.org.
  • VoICE, or the Value of Immunization Compendium of Evidence (VoICE) Tool, is a searchable database that provides advocates with public health evidence for the broader value of vaccines. VoICE is currently available at http://view-hub.org/voice/, and a new site will be unveiled at ISPPD.

See you there!

Can’t make it? Watch our website for a post-symposium recap and poster downloads!